Skip to main content
SpringerLink
Log in

Regulation of Vasopressin and Oxytocin Release in vitro

  • Chapter
Mechanisms of Physical and Emotional Stress

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 245))

Abstract

Numerous studies have demonstrated a role for vasopressin (VP) and oxytocin (OT) in the regulation of adrenocorticotropin (ACTH) release. Both VP and OT release potentiate the effect of corticotropin releasing factor (CRF) on ACTH release (1), and they are present in portal plasma at the concentration required for this action (2). VP and CRF are co-localized in parvicellular neurons in the paraventricular nucleus which project to the median eminence (3–6), and both of these hormones are released from the isolated median eminence following depolarization (7). Thus, this appears to be one source of VP for regulation of ACTH release. OT is also present in some CRF neurons (8), but it has not been established whether these neurons project to the median eminence. Thus, it is not clear which neurons release OT into the portal circulation, but there are OT fibers in the external zone of the median eminence (9) suggesting a specific projection for control of the anterior pituitary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Antoni, F.A., Holmes, M.C., and Jones, M.T., 1983, Oxytocin as well as vasopressin potentiate ovine CRF in vitro, Peptides, 4:411–415.

    Article  PubMed  CAS  Google Scholar 

  2. Gibbs, D.M., 1985, Measurement of hypothalamic corticotropin-releasing factors in hypophyseal portal blood, Fed. Proc., 44:203–206.

    PubMed  CAS  Google Scholar 

  3. Tramu, G., Croix, C., and Pillez, A., 1983, Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material, Neuroendocin., 37:467–469.

    Article  CAS  Google Scholar 

  4. Kiss, J.Z., Mezey, E., and Skirboll, L., 1984, Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy, Proc. Natl. Acad. Sci., 81:1854–1858.

    Article  PubMed  CAS  Google Scholar 

  5. Sawchenko, P.E., Swanson, L.W., and Vale, W.W., 1984, Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat, Proc. Natl. Acad. Sci., 81:1883–1887.

    Article  PubMed  CAS  Google Scholar 

  6. Wolfson, B., Manning, R.W., Davis, L.G., Arentzen, R. and Baldino, F., Jr., 1985, Co-localization of corticotropin releasing factor and vasopressin mRNA in neurons after adrenalectomy, Nature, 315:59–61.

    Article  PubMed  CAS  Google Scholar 

  7. Holmes, M.C., Antoni, F.A., Patt, K.J., Aguilera, G., 1986, Predominant release of vasopressin vs. corticotropin-releasing factor from the isolated median eminence after adrenalectomy, Neuroendocrin., 43:245–251.

    Article  CAS  Google Scholar 

  8. Sawchenko, P.E., Swanson, L.W., and Vale, W.W., 1984, Corticotropinreleasing factor: Co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat, J. Neurosci., 4:1118–1129.

    PubMed  CAS  Google Scholar 

  9. Antunes, J.L. and Zimmerman, E.A., 1978, The hypothalamic magnocellular system of the Rhesis monkey: An immunocytochemical study, J. Comp. Neurol., 181:539–566.

    Article  PubMed  CAS  Google Scholar 

  10. Robertson, G.L., 1977, The regulation of vasopressin function in health and disease, Recent Prog. Horm. Res., 33:333–373.

    Google Scholar 

  11. Sladek, C.D., 1983, Regulation of vasopressin release by neurotransmitters, neuropeptides, and osmotic stimuli, Prog. Brain Res., 60:71–90.

    Article  PubMed  CAS  Google Scholar 

  12. Amico, J.A. and Robinson, A.G., 1985, “Oxytocin,” Excerpta Medica, New York.

    Google Scholar 

  13. Plotsky, P.M., 1985, Hypophyseotropic regulation of adenohypophyseal adrenocorticotropin secretion, Fed. Proc. 44:207–213.

    PubMed  CAS  Google Scholar 

  14. Ungerstedt, J., 1971, Stereotaxic mapping of the monoamine pathways in the rat brain, Acta Physiol. Scand. Suppl., 367:1–48.

    PubMed  CAS  Google Scholar 

  15. Swanson, L.W. and Sawchenko, P.E., 1983, Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei, Ann. Rev. Neurosci., 6:269–324.

    Article  PubMed  CAS  Google Scholar 

  16. McNeill, T.H. and Sladek, J.R., Jr., 1980, Simultaneous monamine histofluorescence and neuropeptide immunocytochemistry: II. Correlative distribution of catecholamine varicosities and magnocellular neurosecretory neurons in the rat supraoptic and paraventricular nuclei, J. Comp. Neurol., 193:1023–1033.

    Article  PubMed  CAS  Google Scholar 

  17. Armstrong, W.E., Sladek, C.D., and Sladek, J.R., 1982, Characterization of noradrenergic control of vasopressin release by the organ cultured rat hypothalamo-neurohypophyseal system, Endocrin., 111:273–279.

    Article  CAS  Google Scholar 

  18. Armstrong, W.E., Gallagher, M.J., and Sladek, C.D., 1986, Noradrenergic stimulation of supraoptic neuronal activity and vasopressin release in vitro: Mediation by an-receptor, Brain Res., 365:192–197.

    Article  PubMed  CAS  Google Scholar 

  19. Randle, J.C.R., Bourque, C.W., and Renaud, L.P., 1984,-Adrenergic activation of rat hypothalamic supraoptic neurons maintained in vitro, Brain Res., 307:374–378.

    Article  PubMed  CAS  Google Scholar 

  20. Willoughby, J.O., Jervois, P.M., Menadue, M.F., and Blessing, W.W., 1987, Noradrenaline, by activation of alpha-1-adrenoceptors in the region of the supraoptic nucleus, causes secretion of vasopressin in the unanaesthetized rat, Neuroendocrin., 45:219–226.

    Article  CAS  Google Scholar 

  21. Spencer, L., Diay, S., Sladek, C., and Leibowity, S.F., 1986, Paraventricular and supraoptic nucleus control of vasopressin release: stimulatory effect of norepinephrine, epinephrine and neuropeptide Y, Soc. for Neurosci. Abs., 12:445.

    Google Scholar 

  22. Blessing, W.W. and Willoughby, J.O., 1985, Inhibiting the rabbit caudal ventrolateral medulla prevents baroreceptor-initiated secretion of vasopressin, J. Physiology 367:253–265.

    CAS  Google Scholar 

  23. Jones, M.T., Gillham, B., DiRenzo, G., Beckford, U., and Holmes, M.C., 1981, Neural control of corticotropin secretion, Front. Horm. Res., 8:12–43.

    CAS  Google Scholar 

  24. Rivier, C.L. and Plotsky, P.M., 1986, Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion, Ann. Rev. Physiol., 48:475–494.

    Article  CAS  Google Scholar 

  25. Waterhouse, B.D., Moises, H.C., Yeh, H.H., and Woodward, D.J., 1982, Norepinephrine enhancement of inhibitory synaptic mechanisms in cerebellum and cerebral cortex: Mediation by beta adrenergic receptors, J. Pharmacol. Exp. Ther., 221:495–506.

    PubMed  CAS  Google Scholar 

  26. Woodward, D.J., Moises, H.C., Waterhouse, B.D., Hoffer, B.J., and Freedman, R., 1979, Modulatory actions of norepinephrine in the central nervous system, Fed. Proc, 38:2109–2116.

    PubMed  CAS  Google Scholar 

  27. Stricker, E.M. and Verbalis, J.G., 1986, Interaction of osmotic and volume stimuli in the regulation of neurohypophyseal secretion in rats, Am. Phys., 250(2):R267–R275.

    CAS  Google Scholar 

  28. van den Pol, A.N., 1985, Dual ultrastructural localization of two neurotransmitter-related antigens: Colloidal gold labelled neurophysin immunoreactive supraoptic neurons receive peroxidase labeled glutamate decarboxylase or gold labelled GABA immunoreactive synapses, J. Neurosci., 5:2940–2954.

    PubMed  Google Scholar 

  29. Burden, J., Hillhouse, E.W., and Jones, M.T., 1974, The inhibitory action of GABA and melatonin on the release of corticotropin releasing hormone from the rat hypophysiotropic area in vitro, J. Physiol., 239:116–117.

    Google Scholar 

  30. Sladek, C.D. and Armstrong, W.E., 1987, GABA antagonists stimulate vasopressin release from organ-cultured hypothalamoneurohypophyseal explants, Endocrin., 120(4).

    Google Scholar 

  31. Meyer, D.K., Oertel, W.H., and Brownstein, M.J., 1980, Deafferentation studies on the glutamic acid decarboxylase content of the supraoptic nucleus of the rat, Brain Res., 200:165–168.

    Article  PubMed  CAS  Google Scholar 

  32. Jhamandes, J.H. and Renaud, L.P., 1986, Pharmacological characterization of an inhibitory baroreceptor-activated projection to supraoptic vasopressinergic neurons, Soc. Neurosci. Abs., 12:538.

    Google Scholar 

  33. Gann, D.S., Dallman, M.F., and Engeland, W.C., 1981, Reflex control and modulation of ACTH and corticosteroids, in: “Endocrine Physiology III, International Review of Physiology.” S.M. McCann, ed., University Park Press, Baltimore.

    Google Scholar 

  34. Keller-Wood, M.E. and Dallman, M.F., 1984, Corticosteriod inhibition of ACTH secretion, Endocrine Rev., 5:1–24.

    Article  CAS  Google Scholar 

  35. Raff, H., 1987, Glucocorticoid inhibition of neurohypophysial vasopressin secretion, Am. J. Physiol., 252.

    Google Scholar 

  36. Olsen, R.W., 1981, GABA-benzodiazepine-barbiturate receptor interactions, J. Neurochemistry, 37:1–13.

    Article  CAS  Google Scholar 

  37. Majewska, M.D., Harrison, N.L., Schwarty, R.D., Barker, J.L., and Paul, S.M., 1986, Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor, Science, 232:1004–1007.

    Article  PubMed  CAS  Google Scholar 

  38. Acs, Z. and Stark, E., 1978, Possible role of gamma-amino butyric acid synthesis in the mechanism of dexamethasone feedback action, J. Endocrine., 77:137–141.

    Article  CAS  Google Scholar 

  39. Acs, Z., Lutz-Bucher, B., Koch, B., and Stark, E., 1985, Vasopressin secretion as a possible target of the-aminobutyric acid-mediated component of the corticosteroid feedback effect, J. Endocrin., 107:303–307.

    Article  CAS  Google Scholar 

  40. Sladek, C.D. and Joynt, R.J., 1979, Characterization of cholinergic control of vasopressin release by the organ cultured rat hypothalamoneurohypophyseal system, Endocrinology, 104:659–663.

    Article  PubMed  CAS  Google Scholar 

  41. Gregg, C.M., 1985, The compartmentalized hypothalamo-neurohypophyseal system: Evidence for a neurohypophyseal action of acetylcholine on vasopressin release, Neuroendocrin., 40(5):423–429.

    Article  CAS  Google Scholar 

  42. Buckingham, J.C and Hodges, J.R., 1979, Hypothalamic receptors influencing the secretion of corticotrophin-releasing hormone in the rat, J. Physiol., 290:421–431.

    PubMed  CAS  Google Scholar 

  43. Calogero, A., et al., this volume.

    Google Scholar 

  44. Armstrong, D.M., Saper, C.B., Levey, A.I., Wainer, B.H., and Terry, R.D., 1983, Distribution of cholinergic neurons in rat brain demonstrated by immunocytochemical localization of choline acetyltransferase, J. Comp. Neural., 216:53–68.

    Article  CAS  Google Scholar 

  45. Meyer, D.K. and Brownstein, M.J., 1980, Effect of surgical deafferentation of the supraoptic nucleus in its choline acetyltransferase content, Brain Res., 193:566–569.

    Article  PubMed  CAS  Google Scholar 

  46. Sladek, C.D. and Joynt, R.J., 1979, Cholinergic involvement in osmotic control of vasopressin release by the organ cultured rat hypothalamoneurohypophyseal system, Endocrinology, 105:367–371.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Neurology and Neurobiology and Anatomy, University of Rochester School of Medicine, Rochester, NY, 14642, USA

    Celia D. Sladek & John A. Olschowka

Authors
  1. Celia D. Sladek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John A. Olschowka
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Institute of Health, Bethesda, Maryland, USA

    George P. Chrousos , D. Lynn Loriaux  & Philip W. Gold ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sladek, C.D., Olschowka, J.A. (1988). Regulation of Vasopressin and Oxytocin Release in vitro. In: Chrousos, G.P., Loriaux, D.L., Gold, P.W. (eds) Mechanisms of Physical and Emotional Stress. Advances in Experimental Medicine and Biology, vol 245. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2064-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2064-5_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-2066-9

  • Online ISBN: 978-1-4899-2064-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation